International trial of the Edmonton protocol for islet transplantation.

Generation of functional human pancreatic β cells in vitro. Cell (2014) 5.90

Recovery from diabetes in mice by beta cell regeneration. J Clin Invest (2007) 4.32

On the origin of the beta cell. Genes Dev (2008) 3.34

Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care (2012) 3.20

Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data. Diabetes (2012) 3.11

In vivo MRI cell tracking: clinical studies. AJR Am J Roentgenol (2009) 2.85

Age-dependent decline in beta-cell proliferation restricts the capacity of beta-cell regeneration in mice. Diabetes (2009) 2.62

Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells. Diabetes (2010) 2.36

A scalable system for production of functional pancreatic progenitors from human embryonic stem cells. PLoS One (2012) 2.24

Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice. Nat Med (2016) 2.15

Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes. Am J Transplant (2012) 2.12

Islet transplantation a decade later and strategies for filling a half-full glass. Diabetes (2010) 2.07

Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab. Am J Transplant (2010) 2.06

Primary graft function, metabolic control, and graft survival after islet transplantation. Diabetes Care (2009) 2.06

The use of exenatide in islet transplant recipients with chronic allograft dysfunction: safety, efficacy, and metabolic effects. Transplantation (2008) 1.83

Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9. Diabetes (2009) 1.78

Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines. PLoS One (2012) 1.76

Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia. Diabetes Care (2016) 1.73

Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes. Am J Transplant (2008) 1.68

Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation. PLoS One (2008) 1.67

Long-term insulin independence and improvement in insulin secretion after supplemental islet infusion under exenatide and etanercept. Transplantation (2008) 1.66

Current advances and travails in islet transplantation. Diabetes (2009) 1.63

ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms. Proc Natl Acad Sci U S A (2008) 1.63

How to make a functional β-cell. Development (2013) 1.58

Cellular plasticity within the pancreas--lessons learned from development. Dev Cell (2010) 1.58

Detailed transcriptome atlas of the pancreatic beta cell. BMC Med Genomics (2009) 1.55

Biological performance of mussel-inspired adhesive in extrahepatic islet transplantation. Biomaterials (2009) 1.55

alpha1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice. Proc Natl Acad Sci U S A (2008) 1.53

The promise and perils of stem cell therapeutics. Cell Stem Cell (2012) 1.50

The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med (2013) 1.50

Banting Lecture 2009: An unfinished journey: molecular pathogenesis to prevention of type 1A diabetes. Diabetes (2010) 1.48

Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation. Am J Transplant (2010) 1.48

Humanized mouse models to study human diseases. Curr Opin Endocrinol Diabetes Obes (2010) 1.48

Interspecies organogenesis generates autologous functional islets. Nature (2017) 1.46

Beta-cell proliferation, but not neogenesis, following 60% partial pancreatectomy is impaired in the absence of FoxM1. Diabetes (2008) 1.46

Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts. Proc Natl Acad Sci U S A (2010) 1.45

Diabetes Is Reversed in a Murine Model by Marginal Mass Syngeneic Islet Transplantation Using a Subcutaneous Cell Pouch Device. Transplantation (2015) 1.44

Agonist of growth hormone-releasing hormone as a potential effector for survival and proliferation of pancreatic islets. Proc Natl Acad Sci U S A (2010) 1.42

Immune rejection after pancreatic islet cell transplantation: in vivo dual contrast-enhanced MR imaging in a mouse model. Radiology (2012) 1.41

Update on islet transplantation. Cold Spring Harb Perspect Med (2012) 1.40

On the diabetic menu: zebrafish as a model for pancreas development and function. Bioessays (2009) 1.38

Islet assessment for transplantation. Curr Opin Organ Transplant (2009) 1.36

Undisclosed changes in outcomes in randomized controlled trials: an observational study. Ann Fam Med (2009) 1.33

Long-term survival of nonhuman primate islets implanted in an omental pouch on a biodegradable scaffold. Am J Transplant (2009) 1.29

Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients. Diabetes (2009) 1.27

The mouse lymph node as an ectopic transplantation site for multiple tissues. Nat Biotechnol (2012) 1.27

Pig pancreas anatomy: implications for pancreas procurement, preservation, and islet isolation. Transplantation (2008) 1.27

Prediction of marginal mass required for successful islet transplantation. J Invest Surg (2010) 1.23

Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade. Transplantation (2010) 1.23

Stem cells to pancreatic beta-cells: new sources for diabetes cell therapy. Endocr Rev (2009) 1.22

Stem cell therapy for type 1 diabetes mellitus. Nat Rev Endocrinol (2010) 1.21

Adenosine kinase inhibition selectively promotes rodent and porcine islet β-cell replication. Proc Natl Acad Sci U S A (2012) 1.21

Indolactam V/GLP-1-mediated differentiation of human iPS cells into glucose-responsive insulin-secreting progeny. Gene Ther (2010) 1.21

Exendin-4 modulates diabetes onset in nonobese diabetic mice. Endocrinology (2007) 1.20

Growth factor delivery from self-assembling nanofibers to facilitate islet transplantation. Transplantation (2008) 1.20

Point: steady progress and current challenges in clinical islet transplantation. Diabetes Care (2009) 1.20

Glucose and aging control the quiescence period that follows pancreatic beta cell replication. Development (2010) 1.19

Trimodal gadolinium-gold microcapsules containing pancreatic islet cells restore normoglycemia in diabetic mice and can be tracked by using US, CT, and positive-contrast MR imaging. Radiology (2011) 1.19

A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice. Diabetes (2010) 1.18

Evidence for rapamycin toxicity in pancreatic β-cells and a review of the underlying molecular mechanisms. Diabetes (2013) 1.17

Use of perfluorocarbon nanoparticles for non-invasive multimodal cell tracking of human pancreatic islets. Contrast Media Mol Imaging (2011) 1.15

Improvement in β-cell secretory capacity after human islet transplantation according to the CIT07 protocol. Diabetes (2013) 1.15

Materials for diabetes therapeutics. Adv Healthc Mater (2012) 1.14

Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist. Proc Natl Acad Sci U S A (2012) 1.14

Layer-by-layer assembly of a conformal nanothin PEG coating for intraportal islet transplantation. Nano Lett (2008) 1.14

Analysis of beta-cell gene expression reveals inflammatory signaling and evidence of dedifferentiation following human islet isolation and culture. PLoS One (2012) 1.13

Treatment of type 1 diabetes with adipose tissue-derived stem cells expressing pancreatic duodenal homeobox 1. Stem Cells Dev (2009) 1.12

Generation of beta cells from human pluripotent stem cells: Potential for regenerative medicine. Semin Cell Dev Biol (2012) 1.12

Regeneration of pancreatic islets in vivo by ultrasound-targeted gene therapy. Gene Ther (2010) 1.12

Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation. Endocr Rev (2008) 1.12

Human pancreatic islets and diabetes research. JAMA (2009) 1.11

Transplantation of human islets without immunosuppression. Proc Natl Acad Sci U S A (2013) 1.10

Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity. Cell (2016) 1.10

Islets transplanted in immunoisolation devices: a review of the progress and the challenges that remain. Endocr Rev (2011) 1.10

Self-assembling nanostructures to deliver angiogenic factors to pancreatic islets. Biomaterials (2010) 1.09

Antigen-specific dependence of Tr1-cell therapy in preclinical models of islet transplant. Diabetes (2009) 1.08

MRI as a tool to monitor islet transplantation. Nat Rev Endocrinol (2009) 1.07

Current status of islet cell transplantation. J Hepatobiliary Pancreat Surg (2008) 1.07

Identification of tissue-specific cell death using methylation patterns of circulating DNA. Proc Natl Acad Sci U S A (2016) 1.06

Multicenter analysis of novel and established variables associated with successful human islet isolation outcomes. Am J Transplant (2010) 1.05

Donor islet endothelial cells in pancreatic islet revascularization. Diabetes (2011) 1.05

Islet-like cell aggregates generated from human adipose tissue derived stem cells ameliorate experimental diabetes in mice. PLoS One (2011) 1.05

Targeting the CXCR4-CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1. J Immunol (2010) 1.04

{beta}-Cell secretory capacity and demand in recipients of islet, pancreas, and kidney transplants. J Clin Endocrinol Metab (2010) 1.04

Reversal of hyperglycemia in diabetic rats by portal vein transplantation of islet-like cells generated from bone marrow mesenchymal stem cells. World J Gastroenterol (2007) 1.03

The Immune Tolerance Network at 10 years: tolerance research at the bedside. Nat Rev Immunol (2010) 1.03

In vivo imaging of autologous islet grafts in the liver and under the kidney capsule in non-human primates. Transplantation (2009) 1.03

Homogeneous insulin and C-Peptide sensors for rapid assessment of insulin and C-peptide secretion by the islets. Diabetes (2010) 1.03

Overcoming immunological barriers in regenerative medicine. Nat Biotechnol (2014) 1.02

Nonvirally modified autologous primary hepatocytes correct diabetes and prevent target organ injury in a large preclinical model. PLoS One (2008) 1.01

Validation of methodologies for quantifying isolated human islets: an Islet Cell Resources study. Clin Transplant (2009) 1.00

HMGB1, an innate alarmin, in the pathogenesis of type 1 diabetes. Int J Clin Exp Pathol (2009) 1.00

The anterior chamber of the eye as a clinical transplantation site for the treatment of diabetes: a study in a baboon model of diabetes. Diabetologia (2011) 1.00

Permanent protection of PLG scaffold transplanted allogeneic islet grafts in diabetic mice treated with ECDI-fixed donor splenocyte infusions. Biomaterials (2011) 1.00

Improved long-term health-related quality of life after islet transplantation. Transplantation (2008) 1.00

Alloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetes. Diabetes (2012) 0.99

Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcome. Rev Diabet Stud (2012) 0.99

Islet transplantation and encapsulation: an update on recent developments. Rev Diabet Stud (2011) 0.98

Human adipose-derived stem cells: potential clinical applications in surgery. Surg Today (2010) 0.98

The current state of pancreas transplantation. Nat Rev Endocrinol (2013) 0.98

Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med (2010) 11.05

Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog (2007) 8.01

Five-year follow-up after clinical islet transplantation. Diabetes (2005) 7.86

A map of open chromatin in human pancreatic islets. Nat Genet (2010) 6.75

Efficacy of remission-induction regimens for ANCA-associated vasculitis. N Engl J Med (2013) 5.67

The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci U S A (2006) 5.41

Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature (2010) 5.16

Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev (2007) 4.91

Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA (2005) 4.48

C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes (2004) 4.44

The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med (2003) 4.20

Common data elements for substance use disorders in electronic health records: the NIDA Clinical Trials Network experience. Addiction (2012) 3.62

Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature (2005) 3.62

Racial variation in medical outcomes among living kidney donors. N Engl J Med (2010) 3.60

How do we define cure of diabetes? Diabetes Care (2009) 3.59

Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation (2005) 3.57

A controlled trial of web-based diabetes disease management: the MGH diabetes primary care improvement project. Diabetes Care (2003) 3.57

Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell (2005) 3.52

Expanding the evidence base in transplantation: the complementary roles of randomized controlled trials and outcomes research. Transplantation (2008) 3.43

Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials. Addiction (2011) 3.42

Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest (2010) 3.41

Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care (2007) 3.40

The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein. Am J Clin Nutr (2008) 3.33

Single port access laparoscopic cholecystectomy (with video). World J Surg (2009) 3.29

Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N Engl J Med (2006) 3.25

Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care (2012) 3.20

Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med (2011) 3.19

Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Arch Gen Psychiatry (2011) 3.15

Single port access laparoscopic right hemicolectomy. Int J Colorectal Dis (2008) 3.08

Minireview: Secondary beta-cell failure in type 2 diabetes--a convergence of glucotoxicity and lipotoxicity. Endocrinology (2002) 3.07

Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant (2005) 3.07

Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes (2010) 2.94

To nap or not to nap? Residents' work hours revisited. N Engl J Med (2009) 2.93

Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1. Diabetes Care (2009) 2.91

Increased islet apoptosis in Pdx1+/- mice. J Clin Invest (2003) 2.91

Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. JAMA (2012) 2.85

2008 Update from the Collaborative Islet Transplant Registry. Transplantation (2008) 2.84

Insulin signaling in alpha cells modulates glucagon secretion in vivo. Cell Metab (2009) 2.83

A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations. Am J Transplant (2005) 2.74

Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes (2002) 2.64

Insulin secretion in type 1 diabetes. Diabetes (2004) 2.59

Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody. Am J Transplant (2004) 2.55

Innervation patterns of autonomic axons in the human endocrine pancreas. Cell Metab (2011) 2.48

Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care (2005) 2.45

Noninvasive in vivo imaging of pancreatic islet cell biology. Nat Med (2008) 2.41

Beta-cell differentiation from nonendocrine epithelial cells of the adult human pancreas. Nat Med (2006) 2.41

Gestational diabetes: new criteria may triple the prevalence but effect on outcomes is unclear. BMJ (2014) 2.40

Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood (2005) 2.39

Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells. Diabetes (2010) 2.36

Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes (2002) 2.36

The emergence of biosimilar insulin preparations--a cause for concern? Diabetes Technol Ther (2012) 2.36

Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis. Arch Gen Psychiatry (2005) 2.35

A prospective, randomized, single-blind comparison of laparoscopic versus open sigmoid colectomy for diverticulitis. Ann Surg (2010) 2.34

Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. Transplantation (2009) 2.33

Mechanical bowel preparation for elective colorectal surgery: a meta-analysis. Arch Surg (2004) 2.32

Glucose metabolism in patients with schizophrenia treated with olanzapine or quetiapine: a frequently sampled intravenous glucose tolerance test and minimal model analysis. J Clin Psychiatry (2006) 2.31

Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 years. Clin Immunol (2009) 2.30

Management of gastrointestinal stromal tumors: from diagnosis to treatment. Swiss Med Wkly (2004) 2.29

IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cells. Hum Mol Genet (2008) 2.27

Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunol (2009) 2.27

Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant (2003) 2.22

Human β cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes. Cell Metab (2012) 2.22

IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells. J Exp Med (2010) 2.21

Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med (2006) 2.21

Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant (2005) 2.19

Comparison of hyperglycemia, hypertension, and hypercholesterolemia management in patients with type 2 diabetes. Am J Med (2002) 2.19

Inactivation of specific β cell transcription factors in type 2 diabetes. J Clin Invest (2013) 2.18

Sensitivity of billing claims for cardiovascular disease events among kidney transplant recipients. Clin J Am Soc Nephrol (2009) 2.17

Mortality assessment for pancreas transplants. Am J Transplant (2004) 2.12

A human beta-cell line for transplantation therapy to control type 1 diabetes. Nat Biotechnol (2005) 2.12

The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma. J Hepatol (2011) 2.12

Two colons-two cancers: paradigm shift and clinical implications. J Surg Oncol (2004) 2.09

Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells. J Clin Invest (2004) 2.09

Unique arrangement of alpha- and beta-cells in human islets of Langerhans. Diabetes (2010) 2.09

Successful pancreas preservation by a perfluorocarbon-based one-layer method for subsequent pig islet isolation. Transplantation (2005) 2.07

Rescue purification maximizes the use of human islet preparations for transplantation. Am J Transplant (2005) 2.04

Single-port access laparoscopic radical left colectomy in humans. Dis Colon Rectum (2009) 2.04

Glutamate is a positive autocrine signal for glucagon release. Cell Metab (2008) 2.01

Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis. J Allergy Clin Immunol (2005) 1.99

Intussusception as a cause of bowel obstruction in adults. Swiss Med Wkly (2005) 1.99

Islet graft assessment in the Edmonton Protocol: implications for predicting long-term clinical outcome. Diabetes (2004) 1.98

Transplant options for patients undergoing total pancreatectomy for chronic pancreatitis. J Am Coll Surg (2004) 1.98